The Australasian Radiation Protection Society's Position Statement on Risks from Low Levels of Ionizing Radiation

Higson, Donald
October 2007
Dose-Response;2007, Vol. 5 Issue 4, p299
Academic Journal
Controversy continues on whether or not ionizing radiation is harmful at low doses, with unresolved scientific uncertainty about effects below a few tens of millisieverts. To settle what regulatory controls should apply in this dose region, an assumption has to be made relating dose to the possibility of harm or benefit. The position of the Australasian Radiation Protection Society on this matter is set out in a statement adopted by the Society in 2005. Its salient features are:� There is insufficient evidence to establish a dose-effect relationship for doses that are less than a few tens of millisieverts in a year. A linear extrapolation from higher dose levels should be assumed only for the purpose of applying regulatory controls.� Estimates of collective dose arising from individual doses that are less than some tens of millisieverts in a year should not be used to predict numbers of fatal cancers.� The risk to an individual of doses significantly less than 100 microsieverts in a year is so small, if it exists at all, that regulatory requirements to control exposure at this level are not warranted.


Related Articles

  • Individual Radiosensitivity and its Relevance to Health Physics. Schnarr, Kara; Dayes, Ian; Sathya, Jinka; Boreham, Douglas // Dose-Response;2007, Vol. 5 Issue 4, p333 

    Radiation protection regulations have been established to reduce exposure of individuals to acceptable safe levels. These limits assume that people have similar responses to ionizing radiation and that there is no variation in individual radiation risk. The purpose of this research was to...

  • B–cell responses: Pass the parcel. Leavy, Olive // Nature Reviews Immunology;Sep2007, Vol. 7 Issue 9, p657 

    The article presents a study that B cells encounter antigenic particle at the subcapsular sinus and can act as antigen-transport cells. B cells are usually found in lymphoid follicles, but large antigen complexes cannot passively diffuse into the follicles. The idea of an antigen-transport cell...

  • TOLL-like receptor ligands stimulate aberrant class switch recombination in early B cell precursors. Efrat Edry; Hilla Azulay-Debby; Doron Melamed // International Immunology;Dec2008, Vol. 20 Issue 12, p1575 

    TOLL-like receptor (TLR) ligands stimulate class switch recombination (CSR) in mature B cells. We showed earlier that developing B cells in the bone marrow (BM) express TLR9 and are responsive to CpG DNA. Since CSR is a critical process for synthesis of effector antibodies, we studied the...

  • Primary Diffuse Large B-Cell Lymphoma of Bone Displays Preferential Rearrangements of the c-MYC or BCL2 Gene. Marina Bousquet; Anne Gomez-Brouchet; Geisilene de Paiva; Eliane Amstalden; Fernando Soares; Nicole Dastugue; Jose Vassallo; Pierre Brousset // American Journal of Clinical Pathology;May2008, Vol. 129 Issue 5, p723 

    We selected a series of 63 primary diffuse large B-cell lymphomas (DLBCLs) of bone collected in tissue microarrays from centers in France and Brazil. These cases were classified according to the expression of antigens associated with germinal center (GC; n = 42) or non-GC (n = 21) stages of...

  • Activation-induced endocytosis of the raft-associated transmembrane adaptor protein LAB/NTAL in B lymphocytes: evidence for a role in internalization of the B cell receptor. Cathlin M. Mutch; Ratna Sanyal; Tammy L. Unruh; Lana Grigoriou; Minghua Zhu; Weiguo Zhang; Julie P. Deans // International Immunology;Jan2007, Vol. 19 Issue 1, p19 

    Linker for activation of B cell (LAB)/non-T cell activation linker (NTAL) and phosphoprotein associated with glycophospholipid-enriched membrane microdomain (PAG)/Csk-binding protein (Cbp) are raft-associated transmembrane adaptor proteins with distinct functions in immediate/early phases of...

  • iNKT Cells Control Mouse Spontaneous Carcinoma Independently of Tumor-Specific Cytotoxic T Cells. Bellone, Matteo; Ceccon, Monica; Grioni, Matteo; Jachetti, Elena; Calcinotto, Arianna; Napolitano, Anna; Freschi, Massimo; Casorati, Giulia; Dellabona, Paolo // PLoS ONE;2010, Vol. 5 Issue 1, p1 

    Background: CD1d-restricted invariant NKT (iNKT) cells are a subset of T lymphocytes endowed with innate effector functions that aid in the establishment of adaptive T and B cell immune responses. iNKT cells have been shown to play a spontaneous protective role against experimental tumors. Yet,...

  • Cephalon Submits Treanda NDA: Orphan Drug For CLL. Osborne, Randall // BioWorld Today;9/24/2007, Vol. 18 Issue 185, p1 

    The article reports that Cephalon Inc. submitted its new drug application for the orphan drug Treanda, which targets chronic B-cell lymphocytic leukemia (CLL) and is being developed for non-Hodgkin's lymphoma as well. Cephalon would make a payment to former shareholders of Salmedix Inc., which...

  • Adjuvant Effect of Killed Propionibacterium acnes on Mouse Peritoneal B-1 Lymphocytes and Their Early Phagocyte Differentiation. Mussalem, Juliana Sekeres; Squaiella-Baptist�o, Carla Cristina; Teixeira, Daniela; Yendo, Tatiana Mina; Thies, Felipe Garutti; Popi, Ana Flavia; Mariano, Mario; Longo-Maug�ri, Ieda // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    B-1 lymphocytes are the predominant cells in mouse peritoneal cavity. They express macrophage and lymphocyte markers and are divided into B-1a, B-1b and B-1c subtypes. The role of B-1 cells is not completely clear, but they are responsible for natural IgM production and seem to play a regulatory...

  • B cell.  // American Heritage Student Science Dictionary;2009, p35 

    A definition of the term "B cell" is presented. The term refers to any of the lymphocytes that develop into plasma cells in the presence of a specific antigen, such as a bacterium or virus. The plasma cells then produce antibodies that attack or neutralize the antigen. B cells mature in the bone...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics